NCT02774395View on ClinicalTrials.gov

Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Endometrial Cancer
Trial Locations (1)

06200

CHU de Nice, Nice

All Listed Sponsors
collaborator

Centre National de la Recherche Scientifique, France

OTHER

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02774395 - Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine | Biotech Hunter | Biotech Hunter